These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31 related articles for article (PubMed ID: 23969716)
1. Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations. Jambon A; Forat M; Marchand C; Morel C; Merienne C; Filali S; Pirot F Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38789246 [TBL] [Abstract][Full Text] [Related]
2. When gravimetry is debated by sponsors of clinical studies. Voidey A; Sommer I; Marino A; Carrez L; Sadeghipour F Eur J Hosp Pharm; 2024 Apr; ():. PubMed ID: 38604614 [No Abstract] [Full Text] [Related]
3. Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. Allen LV; Okeke CC Int J Pharm Compd; 2009; 13(3):234-8. PubMed ID: 23966479 [TBL] [Abstract][Full Text] [Related]
4. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing. Okeke CC; Allen LV Int J Pharm Compd; 2009; 11(5):420-6. PubMed ID: 23966526 [TBL] [Abstract][Full Text] [Related]
5. Basics of compounding: application of the United States pharmacopeia bacterial endotoxins test to compounded sterile preparations. Dawson MF Int J Pharm Compd; 2006; 10():36-9. PubMed ID: 23974125 [TBL] [Abstract][Full Text] [Related]
6. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. Allen LV; Okeke CC Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772 [TBL] [Abstract][Full Text] [Related]
7. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics. Allen LV; Okeke CC Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811 [TBL] [Abstract][Full Text] [Related]
8. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use. Allen LV; Okeke CC Int J Pharm Compd; 2008; 12(3):252-7. PubMed ID: 23969716 [TBL] [Abstract][Full Text] [Related]
9. Quality Assurance and Quality Control, Part 2. Akers MJ Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362 [TBL] [Abstract][Full Text] [Related]
10. Infusate contamination in regional anesthesia: what every anesthesiologist should know. Head S; Enneking FK Anesth Analg; 2008 Oct; 107(4):1412-8. PubMed ID: 18806061 [TBL] [Abstract][Full Text] [Related]
11. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding. Vu N; Nguyen K; Kupiec TC Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116 [TBL] [Abstract][Full Text] [Related]